Replies to post #305407 on Innovation Pharmaceuticals Inc (IPIX)

[PlentyParanoid]

I found something that may help to rate Brilacidin efficacy.
Information is about as scant as with Brilacidin in Covid, but in May merimepodid approved with remdesivir for phase II trial for covid. This article says:

"In preclinical studies of the asset against COVID-19, researchers were stunned to discover highly significant results. The molecule demonstrated an ability to reduce viral replication of SARS-CoV-2 by 98%."
link:
https://www.biospace.com/article/startup-viralclear-drives-antiviral-into-phase-ii-for-covid-19-following-significant-preclinical-results/

Currently I can find very little detail about merimepodid and covid except that 98 % reduction (in which cells?, how soon into incubation?) plus the fact that phase II study will be using oral solution. So, some question marks, as usual. ViralClear has thou .. ahem.. some pedigree, CEO is from Merck.

If 98 % reduction gets phase II in near record time, then how about 97 %.

And I also stand corrected - there is at least one drug with similar efficacy as Brilacidin.